Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 5
2008 6
2009 5
2010 3
2011 2
2012 1
2013 3
2014 1
2015 3
2016 3
2017 5
2018 7
2019 2
2020 3
2021 10
2022 15
2023 9
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Intraperitoneal Carboplatin for Ovarian Cancer - A Phase 2/3 Trial.
Nagao S, Fujiwara K, Yamamoto K, Tanabe H, Okamoto A, Takehara K, Saito M, Fujiwara H, Tan DSP, Yamaguchi S, Adachi S, Kikuchi A, Hirasawa T, Yokoi T, Nagai T, Sato T, Kamiura S, Fujishita A, Loong WW, Chan K, Syks P, Olawaye A, Ryu SY, Shigeta H, Kondo E, Yokoyama Y, Matsumoto T, Hasegawa K, Enomoto T. Nagao S, et al. Among authors: tan dsp. NEJM Evid. 2023 May;2(5):EVIDoa2200225. doi: 10.1056/EVIDoa2200225. Epub 2023 Apr 21. NEJM Evid. 2023. PMID: 38320049 Clinical Trial.
Targeting the immune microenvironment for ovarian cancer therapy.
Blanc-Durand F, Clemence Wei Xian L, Tan DSP. Blanc-Durand F, et al. Among authors: tan dsp. Front Immunol. 2023 Dec 18;14:1328651. doi: 10.3389/fimmu.2023.1328651. eCollection 2023. Front Immunol. 2023. PMID: 38164130 Free PMC article. Review.
Erratum: Closing the gap for cervical cancer research in Vietnam: current perspectives and future opportunities: a report from the 5th Gynecologic Cancer InterGroup (GCIG) Cervical Cancer Research Network (CCRN) Education Symposium.
Phan NTH, Tran QT, Nguyen NPT, Nguyen HT, Tran LDN, Pham VC, Bennett K, Chávez-Blanco A, Plante M, Lecuru FR, Suh DH, Nout R, Tan DSP. Phan NTH, et al. Among authors: tan dsp. J Gynecol Oncol. 2023 Nov;34(6):e89. doi: 10.3802/jgo.2023.34.e89. J Gynecol Oncol. 2023. PMID: 37743061 Free PMC article.
Closing the gap for cervical cancer research in Vietnam: current perspectives and future opportunities: a report from the 5th Gynecologic Cancer InterGroup (GCIG) Cervical Cancer Research Network (CCRN) Education Symposium.
Phan NTH, Tran QT, Nguyen NPT, Nguyen HT, Tran LDN, Pham VC, Bennett K, Chavez-Blanco A, Plante M, Suh DH, Nout R, Tan DSP. Phan NTH, et al. Among authors: tan dsp. J Gynecol Oncol. 2023 Sep;34(5):e88. doi: 10.3802/jgo.2023.34.e88. J Gynecol Oncol. 2023. PMID: 37668081 Free PMC article. No abstract available.
A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies.
Chee CE, Ooi M, Lee SC, Sundar R, Heong V, Yong WP, Ng CH, Wong A, Lim JSJ, Tan DSP, Soo R, Tan JTC, Yang S, Thura M, Al-Aidaroos AQ, Chng WJ, Zeng Q, Goh BC. Chee CE, et al. Among authors: tan dsp. Target Oncol. 2023 May;18(3):391-402. doi: 10.1007/s11523-023-00962-w. Epub 2023 Apr 15. Target Oncol. 2023. PMID: 37060431 Free PMC article. Clinical Trial.
Clinical outcome and prognostic factors for Asian patients in Phase I clinical trials.
Loh J, Wu J, Chieng J, Chan A, Yong WP, Sundar R, Lee SC, Wong A, Lim JSJ, Tan DSP, Soo R, Goh BC, Tai BC, Chee CE. Loh J, et al. Among authors: tan dsp. Br J Cancer. 2023 Apr;128(8):1514-1520. doi: 10.1038/s41416-023-02193-2. Epub 2023 Feb 16. Br J Cancer. 2023. PMID: 36797357 Free PMC article. Clinical Trial.
74 results